International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

COVID 19 and Obesity, a deadly duo? A short commentary

Dr. Navin Kuthiah, Dr. Veeraraghavan Meyyur Aravamudan

Consultant, Department of Medicine, Woodlands Health Campus, Singapore

Article Information

Volume / Issue2 / 4 (October-December 2021)
Pages11-13
AccessOpen Access

Publication Timeline

  • Received29 August 2021
  • Accepted17 September 2021

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

The number of COVID 19 cases worldwide has been increasing steadily in the past few months. Due to the novelty of the virus, we are grappling with uncertainty as our proficiency in severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) and the disease which ensues is in its infancy. The proportion COVID 19 cases with severe disease varies significantly between countries and regions depending on the demographics of those infected. Although most people have mild illness, studies show 12-19% of patients experience severe disease which can lead to mortality. Until the advent of definitive treatment or a vaccine, we must be able to identify the patients at high risk accurately in order to provide closer monitoring and treatment to this cohort of patients. This will allow streamlining of services and resources which are already stretched at this time of a global pandemic. rnStudies have shown older age, cardiovascular disease, diabetes, chronic respiratory disease, inflammatory diseases hypertension, smoking, and cancer were all associated with an increased risk of death in COVID 19. rnAlthough obesity has also been implicated in numerous studies from Asia, Europe and America to cause increased risk of severe disease in COVID 19 patients, it remains understated. rnThis does not come as a surprise as obesity has been linked to worse prognosis in previous flu pandemics (1917 Spanish Flu, 1957 Asian Flu, 1968 Hong Kong Flu and 2009 H1N1 pandemic).

Keywords

COVID19Obesity

References

  1. Wu Z, Mc Googan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 doi: 10.1001/jama. 2020.2648. [Google Scholar][Crossref]
  2. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020 doi:10.1001/jama.2020.4683 [Google Scholar][Crossref]
  3. Zhang J, Wang X, Dong W, et al. Risk factors for disease severity, un-improvement, and mortality in COVID-19 patients in Wuhan, China. Clinical Microbiology and Infection 2020 https://doi.org/10.1016/j.cmi.2020.04.012 [Google Scholar][Crossref]
  4. Peng YD, Meng K, Guan HQ, et al. Clinical characteristics, and outcomes of 112 cardiovascular disease patients infected by 2019‐nCoV. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48(0):E004. Doi: 10.3760/cma.j.cn112148-20200220-00105 [Google Scholar][Crossref]
  5. Qingxian C, Fengjuan C, Fang L, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Lancet (Preprint), 2020. http://dx.doi.org/10.2139/ssrn.3556658 [Google Scholar][Crossref]
  6. Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity, 2020, 9. Doi: 10.1002/oby.22831. [Google Scholar][Crossref]
  7. Buscemi S, Buscemi C, Batsis JA. There is a relationship between obesity and COVID-19 but more information is needed. Preprints, 2020. Doi: 10.1002/oby.22883 [Google Scholar][Crossref]
  8. Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis, 2020. Pii: ciaa415. Doi: 10.1093/cid/ciaa415. [Google Scholar][Crossref]
  9. Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020. Doi: 10.1056/NEJMc2010419. [Google Scholar][Crossref]
  10. Luzi L, Radaelli MG. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetologica , 2020 https://doi.org/10.1007/s00592-020-01522-8 [Google Scholar][Crossref]
  11. www.who.int/gho/ncd/risk_factors/overweight /en/ [Google Scholar][Crossref]
  12. Newton S, Braithwaite D, Akinyemiju TF. Socio-economic status over the life course and obesity: Systematic review and meta-analysis. PLoS ONE. 2017; 12(5):e0177151. https://doi.org/10.1371/journal.pone.0177151. [Google Scholar][Crossref]
  13. Bhatt J, Bathija P. Ensuring Access to Quality Health Care in Vulnerable Communities. Acad Med. 2018; 93:1271-1275. Doi: 10.1097/ACM.0000000000002254. [Google Scholar][Crossref]
  14. European Centre for Disease Prevention and Control https://www.ecdc.europa.eu/en. [Google Scholar][Crossref]
  15. Julia B. Limitations of Body Mass Index to Assess Body Fat. Workplace Health and Safety. 2014; 62(6):264. Doi: 10.1177/216507991406200608 [Google Scholar][Crossref]
  16. Srikanthan P, Seeman TE, Karlamangla AS. Waist-hip-ratio as a Predictor of All-Cause Mortality in High-Functioning Older Adults. Ann Epidemiol. 2009; 19(10):724-31. Doi: 10.1016/j.annepidem.2009.05.003. [Google Scholar][Crossref]
  17. Chiappetta S, Sharma AM, Bottino V, Stier C. COVID-19 and the role of chronic inflammation in patients with obesity. International Journal of Obesity, 2020. https://doi.org/10.1038/s41366-020-0597-4 [Google Scholar][Crossref]
  18. Hainer V Aldhoon-Hainerova I. Obesity Paradox Does Exist. Diabetes Care . 2013; 36:S2. https://doi.org/10.2337/dcS13-2023 [Google Scholar][Crossref]
  19. Ades PA, Savage PD. The Obesity Paradox: Perception vs Knowledge. Mayo Clin Proc. 2010; 85(2):112-114. Doi: 10.4065/mcp.2009.0777 [Google Scholar][Crossref]
  20. Andrade C. J Clin Psychiatry. The Primary Outcome Measure and Its Importance in Clinical Trials 2015; 76(10):e1320-3. Doi: 10.4088/JCP.15f10377. [Google Scholar][Crossref]
  21. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373(9669):1083-1096. Doi: 10.1016/S0140-6736(09)60318-4 [Google Scholar][Crossref]
  22. Ashburn DD, De-Antonio A, Reed MJ. Pulmonary system and obesity. Crit Care Clin. 2010; 26:597-602 https://doi.org/10.1016/j.ccc.2010.06.008 [Google Scholar][Crossref]
  23. Vachharajani V, Russell JM, Scott KL, et al. Obesity exacerbates sepsis induced inflammation and micro-vascular dysfunction in mouse brain. Microcirculation 2005; 12:183 -94. https://doi.org/10.1080/10739680590904982 [Google Scholar][Crossref]
  24. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19 Lancet Haematol , 2020. https://doi.org/10.1016/S2352-3026(20)30145-9 [Google Scholar][Crossref]
  25. Fernandez C, Manuel A. Obesity, respiratory disease and pulmonary infections. Ann Res Hosp. 2017; 1:38. http://dx.doi.org/10.21037/arh.2017.08.06 [Google Scholar][Crossref]
  26. Patel AB, Verma A. COVID‐19 and angiotensin‐ converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. 2020; 323(18):1769-1770. Doi:10.1001/jama.2020.4812. [Google Scholar][Crossref]
  27. Lei Zhao. Obesity accompanying COVID 19: the role of epicardial fat. Obesity , 2020. https://doi.org/10.1002/oby.22867 [Google Scholar][Crossref]
  28. Gurusaravanan kutti sridharan, Radhakrishna Vegunta et al. Venous thromboembolism inHospitalized COVID 19 Patients. American Journal of Therapeutics. 2020; 27(6):e599-e610.2. Doi:10.1097/MJT.0000000000001295. [Google Scholar][Crossref]
  29. Metabolic associated fatty liver disease and COVID-19: a double whammy? Singapore Med J . Doi: 10.11622/smedj.2020141Hui Xian Jaime Lin 1, Veeraraghavan Meyyur Aravamudan 1 [Google Scholar][Crossref]

How to Cite

Kuthiah, N., & Aravamudan, V. M. (2021). COVID 19 and Obesity, a deadly duo? A short commentary. International Journal of Medical and All Body Health Research, 2(4), 11-13.

Kuthiah, Navin, and Veeraraghavan Meyyur Aravamudan. "COVID 19 and Obesity, a deadly duo? A short commentary." International Journal of Medical and All Body Health Research, vol. 2, no. 4, 2021, pp. 11-13.

Kuthiah, N. and Aravamudan, V. M. (2021) 'COVID 19 and Obesity, a deadly duo? A short commentary', International Journal of Medical and All Body Health Research, 2(4), pp. 11-13.

Kuthiah N, Aravamudan VM. COVID 19 and Obesity, a deadly duo? A short commentary. International Journal of Medical and All Body Health Research. 2021;2(4):11-13.

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex ResearchGate BASE

A newly published article may take a few days to appear on these services.